Skip to main content

Table 6 The ratios of mRNA expression levels of Thy-1 or MMP-9 to that of β-actin

From: Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase

Group

1

2

3

4

Thy-1/β-actin (n = 5)

0.99 ± 0.38

0.31 ± 0.15**

0.45 ± 0.20

0.78 ± 0.32†

MMP-9/β-actin (n = 3–4)

0.75 ± 0.55

4.44 ± 0.84**

3.01 ± 1.90

1.13 ± 0.34††

  1. In retinal ischemia plus 24 h of reperfusion (I/R), total mRNA was extracted and isolated from the sham procedure retinas (Group 1) or the ischemic retinas preadministered with vehicle (Group 2), or low (2.8 g/kg/day; Group 3)/high dose (4.2 g/kg/day) of CJDHW (Group 4)
  2. CJDHW Chi-Ju-Di-Huang-Wan
  3. ** represents significance (P < 0.01; Group 1 vs. 2)
  4. † or †† represents significance for Thy-1 (P < 0.05) or significance for MMP-9 (P < 0.01; Group 2 vs. 4), respectively. The findings are presented as the mean ± SD (Thy-1, n = 5; MMP-9, n = 3–4)